{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["4(2)"],"submitter":["David JM"],"pubmed_abstract":["<h4>Purpose</h4>Locally advanced pancreatic cancer (LAPC) treatment has varying practice patterns with poor outcomes. We investigated treatment using single-agent chemotherapy and multiagent chemotherapy (MAC) with or without radiation therapy (RT) at high-volume facilities (HVFs) and academic centers (ACs).<h4>Methods and materials</h4>The National Cancer Database was used to obtain data on 10,139 patients with LAPC. HVF was defined as the top 5% of facilities per number of patients treated at each facility. Univariate and multivariable (MVA) analysis Cox regressions were performed to identify the impact of HVF, AC, MAC, and RT on overall survival (OS).<h4>Results</h4>The median age of patients was 66 years (range, 22-90); 50.1% were male and 49.9% female. Of the patients, 46.1% received "],"journal":["Advances in radiation oncology"],"pagination":["302-313"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6460104"],"repository":["biostudies-literature"],"pubmed_title":["Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers."],"pmcid":["PMC6460104"],"pubmed_authors":["Kim S","David JM","Hendifar A","Placencio-Hickok VR","Tuli R","Torosian A"],"additional_accession":[]},"is_claimable":false,"name":"Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers.","description":"<h4>Purpose</h4>Locally advanced pancreatic cancer (LAPC) treatment has varying practice patterns with poor outcomes. We investigated treatment using single-agent chemotherapy and multiagent chemotherapy (MAC) with or without radiation therapy (RT) at high-volume facilities (HVFs) and academic centers (ACs).<h4>Methods and materials</h4>The National Cancer Database was used to obtain data on 10,139 patients with LAPC. HVF was defined as the top 5% of facilities per number of patients treated at each facility. Univariate and multivariable (MVA) analysis Cox regressions were performed to identify the impact of HVF, AC, MAC, and RT on overall survival (OS).<h4>Results</h4>The median age of patients was 66 years (range, 22-90); 50.1% were male and 49.9% female. Of the patients, 46.1% received ","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Apr-Jun","modification":"2025-06-01T03:57:35.319Z","creation":"2025-06-01T03:57:35.319Z"},"accession":"S-EPMC6460104","cross_references":{"pubmed":["31011675"],"doi":["10.1016/j.adro.2018.10.006"]}}